A new position paper presents an up-to-date review and expert recommendations using the GRADE methodology to inform the implementation of trabecular bone score (TBS)* in clinical practice for the management ...

The first study to define analytical performance specifications for 24,25-dihydroxyvitamin D examinations has been published by an expert working group of the International Federation of Clinical Chemistry and Laboratory Medicine ...

A new position paper by the International Osteoporosis Foundation (IOF) and European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) addresses the rationale for separate ...

The International Osteoporosis Foundation (IOF) Epidemiology and Quality of Life Working Group has reviewed the potential role of population screening for high hip fracture risk against well-established criteria.  The multinational ...

The UK National Osteoporosis Guideline Group (NOGG) has just launched its new UK Guideline for ‘The Prevention and Treatment of Osteoporosis’, which has received accreditation from the National ...

Fragility fractures, which affect an estimated one in three women and one in five men over the age of 50 years worldwide, are a major cause of disability and loss ...

Vascular calcification, low bone mass and fragility fractures are all frequent age-dependent disorders. Recent clinical and experimental data suggest that vascular calcification and bone loss could share pathophysiological mechanisms. 

A ...

Asian countries are facing the most marked increase in fragility fractures globally, with the number of people at high fracture risk expected to double from 2010-2030. By 2050 approximately half ...

Patients with advanced chronic kidney disease (CKD) typically suffer from impaired bone quality and quantity, with a non-vertebral fracture risk which is 4-to 6-fold higher than the fracture risk of ...

Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant haematological diseases. 

To address this ...

A new study by the IFCC‑IOF Committee for Bone Metabolism shows large within- and between-assay variation for ß-CTX measurement; until harmonization is achieved, proposes measuring ß-CTX by the same assay ...

Joint Guidance on COVID-19 Vaccination and Osteoporosis Management from the American Society for Bone and Mineral Research (ASBMR), American Association of Clinical Endocrinology (AACE), Endocrine Society, European Calcified Tissue Society ...